102 related articles for article (PubMed ID: 27936729)
41. Surface Modification of Gd Nanoparticles with pH-Responsive Block Copolymers for Use As Smart MRI Contrast Agents.
Zhu L; Yang Y; Farquhar K; Wang J; Tian C; Ranville J; Boyes SG
ACS Appl Mater Interfaces; 2016 Feb; 8(7):5040-50. PubMed ID: 26790986
[TBL] [Abstract][Full Text] [Related]
42. Charge-conversional PEG-polypeptide polyionic complex nanoparticles from simple blending of a pair of oppositely charged block copolymers as an intelligent vehicle for efficient antitumor drug delivery.
Lv S; Song W; Tang Z; Li M; Yu H; Hong H; Chen X
Mol Pharm; 2014 May; 11(5):1562-74. PubMed ID: 24606535
[TBL] [Abstract][Full Text] [Related]
43. Biodegradable brush-type copolymer modified with targeting peptide as a nanoscopic platform for targeting drug delivery to treat castration-resistant prostate cancer.
Liu T; Huang Q
Int J Pharm; 2016 Sep; 511(2):1002-11. PubMed ID: 27521701
[TBL] [Abstract][Full Text] [Related]
44. High-relaxivity and luminescent silica nanoparticles as multimodal agents for molecular imaging.
Lipani E; Laurent S; Surin M; Vander Elst L; Leclère P; Muller RN
Langmuir; 2013 Mar; 29(10):3419-27. PubMed ID: 23383648
[TBL] [Abstract][Full Text] [Related]
45. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
[TBL] [Abstract][Full Text] [Related]
46. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
[TBL] [Abstract][Full Text] [Related]
47. Facile Synthesis of Gd-Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging.
Yang W; Guo W; Gong X; Zhang B; Wang S; Chen N; Yang W; Tu Y; Fang X; Chang J
ACS Appl Mater Interfaces; 2015 Aug; 7(33):18759-68. PubMed ID: 26257133
[TBL] [Abstract][Full Text] [Related]
48. Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor.
Shalviri A; Foltz WD; Cai P; Rauth AM; Wu XY
J Control Release; 2013 Apr; 167(1):11-20. PubMed ID: 23353806
[TBL] [Abstract][Full Text] [Related]
49. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
50. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
51. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
52. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
Shen H; Hu D; Du J; Wang X; Liu Y; Wang Y; Wei JM; Ma D; Wang P; Li L
Eur J Pharmacol; 2008 Dec; 601(1-3):23-9. PubMed ID: 18983839
[TBL] [Abstract][Full Text] [Related]
53. Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
Prashant C; Dipak M; Yang CT; Chuang KH; Jun D; Feng SS
Biomaterials; 2010 Jul; 31(21):5588-97. PubMed ID: 20434210
[TBL] [Abstract][Full Text] [Related]
54. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
55.
Banerjee SR; Foss CA; Horhota A; Pullambhatla M; McDonnell K; Zale S; Pomper MG
Biomacromolecules; 2017 Jan; 18(1):201-209. PubMed ID: 28001364
[TBL] [Abstract][Full Text] [Related]
56. A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo.
Teo J; McCarroll JA; Boyer C; Youkhana J; Sagnella SM; Duong HT; Liu J; Sharbeen G; Goldstein D; Davis TP; Kavallaris M; Phillips PA
Biomacromolecules; 2016 Jul; 17(7):2337-51. PubMed ID: 27305597
[TBL] [Abstract][Full Text] [Related]
57. Green Synthesis of Sub-10 nm Gadolinium-Based Nanoparticles for Sparkling Kidneys, Tumor, and Angiogenesis of Tumor-Bearing Mice in Magnetic Resonance Imaging.
Zhang B; Yang W; Yu J; Guo W; Wang J; Liu S; Xiao Y; Shi D
Adv Healthc Mater; 2017 Feb; 6(4):. PubMed ID: 28004887
[TBL] [Abstract][Full Text] [Related]
58. Light-triggered concomitant enhancement of magnetic resonance imaging contrast performance and drug release rate of functionalized amphiphilic diblock copolymer micelles.
Li Y; Qian Y; Liu T; Zhang G; Liu S
Biomacromolecules; 2012 Nov; 13(11):3877-86. PubMed ID: 23013152
[TBL] [Abstract][Full Text] [Related]
59. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
[TBL] [Abstract][Full Text] [Related]
60. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging.
Ye M; Qian Y; Tang J; Hu H; Sui M; Shen Y
J Control Release; 2013 Aug; 169(3):239-45. PubMed ID: 23403397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
